BROADWAY GOLD MINING Forum: Community User: Pälzer

Because Everyone Keeps Asking - MindMed Clinical Trials Ending in 2021 I've noticed that many people keep asking when we will have clinical trial results. In order to help prevent the spread of misinformation, FUD, and manage expectations of the MNMD share price, I thought I'd share what clinical trials are ending in 2021. There are 3 trials ENDING this year and we should be very excited for the results. A Phase 2a for LSD for Anxiety - expected completion May 1, 2021 A Phase 1 for 18-MC for addiction - expected completion August 1, 2021 A Phase 1 for Ketanserin as a LSD Neutralizer - expected completion October 1, 2021 These are either sponsored by MindMed or University Hospital, Basel, Switzerland (We have the exclusive rights to their data). NOTE: Just because the trial is ending on a certain date, it does not mean that MindMed will share results at that point in time. They may, but there is nothing that requires them to release data immediately after the trial completion date. I note this because many people are asking when trial data comes out and are expecting an immediate bump in share price. Do not expect this to happen immediately. Right now, all we know is when the expected completion date is based on [clinicaltrials.gov](https://clinicaltrials.gov). And from that its clear that we have plenty to look forward to this year. But remember, the most value for this stock comes from the LONG hold. The Phase 2a for LSD and Anxiety ends on May 1...just 2 days away! While this is absolutely exciting, this does not mean that stock will moon next Monday. Don't forget, we are also in a quiet period due to the Nasdaq up-listing that wont end until (later next week?). BUT when they do release data and IF the data looks great, which many of us expect it will, then things will look very bright for MNMD!!!

Hatte ich geschrieben RL zu ca. 2,5 dann long kristallklar

sieht nicht gut aus

Hoffentlich

Jetzt pumpen die wieder Geld bis morgen rein

Genau. ****

Wir pushen die kassieren wie immer

Amis machen alles kaputt

Amis

Verstehe ich nicht. Vormittag bzw früh 4,19€ und jetzt 3,55€😂😂

Geht nach hinten los

Klingt vernünftig und wär ja solide wenn es dann auf dem Niveau erstmal bleibt

Ich hab jetzt mal Mindmed mit Compass Pathways verglichen ,ich glaub nicht das der Kurs im moment extrem steigen wird zumindest nicht ohne News .Wir haben ungefähr die selbe Marktkapitalisierung wie Compass Pathways und werden sozusagen gleich bewertet kein Umsatz kein Produkt von daher kann ich mir nicht vorstellen warum Mindmed deutlich besser bewertet werden sollte.

5 € auf langer Sicht auch

Also die 4 Euro als schlusskurs sind heute möglich

Vielleicht werde ich ja trotz 5€ noch belohnt hier eingestiegen zu sein wenn ich nur lang halte